-
Aplaviroc (INN,
codenamed AK602 and GSK-873140) is a CCR5
entry inhibitor that
belongs to a
class of 2,5-****topiperazines
developed for the treatment...
- approved:[citation needed]
GlaxoSmithKline (GSK) with
their compound aplaviroc,[citation needed] Schering-Plough with vicriviroc,[citation needed] and...
- (Sanofi-Aventis), also
known as
insulin apilimod (INN)
apixaban (USAN, INN)
aplaviroc (USAN, INN)
aplindore (USAN)
Aplisol Aplitest Apogen Apokyn apolizumab...
- (MIP-1α) CCL4 (MIP-1β) CCL5 (RANTES) CCL8 CCL11 CCL13 CCL14 CCL16 NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies:...
- (MIP-1α) CCL4 (MIP-1β) CCL5 (RANTES) CCL8 CCL11 CCL13 CCL14 CCL16 NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies:...
- (MIP-1α) CCL4 (MIP-1β) CCL5 (RANTES) CCL8 CCL11 CCL13 CCL14 CCL16 NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies:...
- (MIP-1α) CCL4 (MIP-1β) CCL5 (RANTES) CCL8 CCL11 CCL13 CCL14 CCL16 NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies:...
- Tre
recombinase Zinc
finger protein transcription factor Failed agents Aplaviroc Atevirdine Brecanavir Capravirine Dexelvucitabine Droxinavir Lasinavir...
-
Vicriviroc (Phase III
trials were
cancelled in July 2010) (Schering Plough),
Aplaviroc (GW-873140) (GlaxoSmithKline) and
Maraviroc (UK-427857) (Pfizer). Maraviroc...
- (MIP-1α) CCL4 (MIP-1β) CCL5 (RANTES) CCL8 CCL11 CCL13 CCL14 CCL16 NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies:...
